Thrombotic microangiopathy
| Thrombotic microangiopathy | |
| ICD-10 | M31.1 |
|---|---|
| ICD-9 | 446.6 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Thrombotic microangiopathies are a category of pathologies that result in thrombosis in capillaries and arterioles.[1] This process leads to thrombocytopenia and a variety of other symptoms such as: anemia, purpura, renal failure (some), schistocytes (fragmented blood cells severed by fibrin products) and ischemic injury to cells.
Categories
Bacterial toxins are the primary cause of one category of thrombotic microangiopathy known as HUS or hemolytic uremic syndrome. The other major category is TTP or thrombotic thrombocytopenic purpura caused by autoimmune or hereditary dysfunctions that activate the coagulation cascade or the complement system.
Some sources group TTP and HUS together[2], while other sources express skepticism about their common pathophysiology.[3]
Presentation
The clinical presentation typically includes: fever, microangiopathic hemolytic anemia (see schistocytes in a blood smear), renal failure, thrombocytopenia, neurological manifestations.
See also
References
Template:Vascular diseases Template:Diseases of the musculoskeletal system and connective tissue Template:SIB